## Opioid Overdose Management: Acute Respiratory Depression **Key Point:** Naloxone is a competitive opioid antagonist that rapidly reverses opioid-induced respiratory depression, CNS depression, and hypotension. It is the gold standard for acute opioid toxicity. ### Clinical Presentation Recognition This patient exhibits the classic **opioid toxicity triad**: 1. Respiratory depression (RR 8/min — critical) 2. Pinpoint pupils (miosis) 3. Altered mental status / coma Additional signs: hypotension, bradycardia (though this patient has tachycardia from hypoxia and compensation). ### Naloxone Administration Protocol | Parameter | Detail | |-----------|--------| | **Dose** | 0.4–0.8 mg IV bolus (or 2 mg IM/IN if IV access unavailable) | | **Repeat** | Every 2–3 minutes, up to 10 mg total | | **Onset** | 1–2 minutes IV; 2–3 minutes IM/IN | | **Duration** | 30–90 minutes (shorter than morphine) | | **Mechanism** | Competitive antagonism at μ-opioid receptors | **High-Yield:** Naloxone duration is **shorter than most opioids** (especially long-acting formulations like morphine). Repeat dosing or continuous infusion may be needed to prevent re-sedation. ### Why Naloxone Is the Answer - Immediate reversal of life-threatening respiratory depression - No risk of worsening the clinical state (pure antagonist) - Allows time for supportive care and investigation of the overdose cause - Can be given IV, IM, or intranasal — rapid access **Clinical Pearl:** In a cancer patient on chronic opioids, accidental overdose can occur from: - Dose escalation without tolerance adjustment - Drug interactions (CYP3A4 inhibitors) - Renal/hepatic impairment reducing clearance - Concurrent sedatives or alcohol Naloxone reversal may precipitate acute withdrawal (agitation, tachycardia, diaphoresis) but this is preferable to death from hypoxia.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.